In a report released today, Michael Yee from Jefferies maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of ...

The market has climbed by 5.8% over the past week, and is up 4.8% over the past year, with earnings expected to grow by 14% per annum in the coming years. Though the term 'penny stock' might sound ...

Biotech leading the charge Until not so long ago, Moderna was a medium-sized biotech working in the niche space of mRNA. Prior to the pandemic, biotech had a market cap of around $6.5bn whereas ...

The YieldMax Magnificient 7 Fund of Option Income ETFs has outperformed the market since launch but I do not expect that to ...

Patients with an advanced type of skin melanoma in England will be given expedited access to a new vaccine being developed by ...

Kailera jumped the weight loss miracle-drug line by licensing four clinical-stage obesity therapies from China, which is ...

Learn more about whether Ionis Pharmaceuticals, Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's ...

As the U.S. market navigates a turbulent landscape marked by volatile trading sessions and fluctuating economic indicators, investors are closely watching the impact of ongoing tariff developments and ...

Daiichi Sankyo Company, Limited leads in ADC tech with Enhertu, strong partnerships, revenue growth, and global market leadership. Click to know more on why DSNKY is a Buy.

Targovax ASA ( ($GB:0RIS) ) just unveiled an update. Circio Holding ASA’s Board of Directors has approved the company’s 2024 Annual Report, which ...

We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going ...